CompletedNCT02532686
Add-On DAAOI-2 for Treatment-Resistant Schizophrenia
About this title
Read the official source — NCT02532686Medication studyAges 18–65Taiwan
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- TaichungSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateOctober 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- China Medical University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Taiwan
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02532686
- Official title
Show the full official title
DAAOI-2 add-on Treatment for Treatment-resistant Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Taichung
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is China Medical University Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including DAAOI-2 and placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
